Lipocine (LPCN) Non Operating Income (2017 - 2025)
Lipocine's Non Operating Income was $174,208 in Q3 2025, down 57.7% from $411,655 a year earlier and down 12.3% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Non Operating Income (2017 - 2025) Analysis & Trends
On a trailing twelve-month basis, Lipocine's Non Operating Income was $835,060 through Sep 30, 2025, down 32.6% year-over-year; for FY2024, it came in at $1.16 million, down 26.3% from FY2023.
- In earlier years, Non Operating Income was $1.58 million in FY2023 (+16.0%) and $1.36 million in FY2022.
- The Q3 2025 figure marks the lowest quarterly Non Operating Income since Q3 2018.
- Compared with a year earlier, Non Operating Income has declined for four straight quarters, with an average decline of 24.9% over the last eight quarters.
- The best year-over-year quarter for Non Operating Income over five years was Q3 2024 (growth of 4.9%); the worst was Q3 2025 (a decline of 57.7%).
- Per Business Quant data, LPCN's Non Operating Income in the three quarters before Q3 2025 was $198,637 (Q2 2025), $225,511 (Q1 2025) and $236,704 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Lipocine | 11.92 Mn | -55.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 174,208.00 |
| Jun 30, 2025 | 198,637.00 |
| Mar 31, 2025 | 225,511.00 |
| Dec 31, 2024 | 236,704.00 |
| Sep 30, 2024 | 411,655.00 |
| Jun 30, 2024 | 224,415.00 |
| Mar 31, 2024 | 291,292.00 |
| Dec 31, 2023 | 311,653.00 |
| Sep 30, 2023 | 392,396.00 |
| Jun 30, 2023 | 406,976.00 |
| Mar 31, 2023 | 468,603.00 |
| Dec 31, 2022 | 331,401.00 |
| Sep 30, 2022 | 490,206.00 |
| Jun 30, 2022 | 895,754.00 |
| Sep 30, 2018 | -106,016.00 |
| Jun 30, 2018 | -91,091.00 |
| Mar 31, 2018 | -82,285.00 |
| Sep 30, 2017 | 65,811.00 |
| Jun 30, 2017 | 50,852.00 |
| Mar 31, 2017 | 48,355.00 |
API Access
Lipocine Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();